MARKET

MGX

MGX

Metagenomi Therapeutics, Inc
NASDAQ
1.310
-0.040
-2.96%
After Hours: 1.310 0 0.00% 16:10 05/15 EDT
OPEN
1.330
PREV CLOSE
1.350
HIGH
1.351
LOW
1.300
VOLUME
143.04K
TURNOVER
--
52 WEEK HIGH
3.950
52 WEEK LOW
1.250
MARKET CAP
49.32M
P/E (TTM)
-0.5704
1D
5D
1M
3M
1Y
5Y
1D
Analysts Have Lowered Expectations For Metagenomi Therapeutics, Inc. (NASDAQ:MGX) After Its Latest Results
Simply Wall St · 2d ago
Analysts Are Bullish on Top Healthcare Stocks: Metagenomi, Inc. (MGX), Sionna Therapeutics, Inc. (SION)
TipRanks · 3d ago
Metagenomi Price Target Cut to $9.00/Share From $12.00 by Wells Fargo
Dow Jones · 4d ago
Metagenomi Is Maintained at Overweight by Wells Fargo
Dow Jones · 4d ago
Wells Fargo Maintains Overweight on Metagenomi Therapeutics, Lowers Price Target to $9
Benzinga · 4d ago
METAGENOMI THERAPEUTICS, INC. <MGX.O>: WELLS FARGO CUTS TARGET PRICE TO $9 FROM $12
Reuters · 4d ago
Wells Fargo Keeps Their Buy Rating on Metagenomi, Inc. (MGX)
TipRanks · 4d ago
Metagenomi price target lowered to $9 from $12 at Wells Fargo
TipRanks · 4d ago
More
About MGX
Metagenomi Therapeutics, Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. It is developed to discover and develop a suite of novel editing tools potentially capable of correcting any type of genetic mutation found anywhere in the human genome. It focuses on high value programs in disease indications with well-understood biology and clearly defined clinical development and regulatory pathways. MGX-001, its lead, wholly owned development program in hemophilia A, has demonstrated a preclinical profile potentially competitive with treatment options, including targeted genome editing and durable gene expression in a one-time treatment. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A. MGX-001 is designed to insert a Factor VIII (FVIII) DNA cassette into a safe harbor location within an intron of the albumin gene.

Webull offers Metagenomi Therapeutics Inc stock information, including NASDAQ: MGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGX stock methods without spending real money on the virtual paper trading platform.